1. Home
  2. RPRX vs CASY Comparison

RPRX vs CASY Comparison

Compare RPRX & CASY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RPRX
  • CASY
  • Stock Information
  • Founded
  • RPRX 1996
  • CASY 1959
  • Country
  • RPRX United States
  • CASY United States
  • Employees
  • RPRX N/A
  • CASY N/A
  • Industry
  • RPRX Biotechnology: Pharmaceutical Preparations
  • CASY Diversified Commercial Services
  • Sector
  • RPRX Health Care
  • CASY Miscellaneous
  • Exchange
  • RPRX Nasdaq
  • CASY Nasdaq
  • Market Cap
  • RPRX 14.2B
  • CASY 14.3B
  • IPO Year
  • RPRX 2020
  • CASY N/A
  • Fundamental
  • Price
  • RPRX $31.03
  • CASY $420.58
  • Analyst Decision
  • RPRX Strong Buy
  • CASY Buy
  • Analyst Count
  • RPRX 5
  • CASY 11
  • Target Price
  • RPRX $41.60
  • CASY $424.00
  • AVG Volume (30 Days)
  • RPRX 4.7M
  • CASY 430.2K
  • Earning Date
  • RPRX 05-08-2025
  • CASY 03-11-2025
  • Dividend Yield
  • RPRX 2.77%
  • CASY 0.45%
  • EPS Growth
  • RPRX N/A
  • CASY 14.10
  • EPS
  • RPRX 1.91
  • CASY 14.35
  • Revenue
  • RPRX $2,263,576,000.00
  • CASY $15,548,156,000.00
  • Revenue This Year
  • RPRX $34.04
  • CASY $9.20
  • Revenue Next Year
  • RPRX $6.10
  • CASY $11.05
  • P/E Ratio
  • RPRX $16.63
  • CASY $31.31
  • Revenue Growth
  • RPRX N/A
  • CASY 6.56
  • 52 Week Low
  • RPRX $24.05
  • CASY $306.45
  • 52 Week High
  • RPRX $34.20
  • CASY $458.70
  • Technical
  • Relative Strength Index (RSI)
  • RPRX 36.17
  • CASY 67.36
  • Support Level
  • RPRX $30.82
  • CASY $391.55
  • Resistance Level
  • RPRX $31.85
  • CASY $436.64
  • Average True Range (ATR)
  • RPRX 0.76
  • CASY 12.60
  • MACD
  • RPRX -0.25
  • CASY 5.38
  • Stochastic Oscillator
  • RPRX 9.57
  • CASY 86.88

About RPRX Royalty Pharma plc

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.

About CASY Casey's General Stores Inc.

Casey's serves as the nation's third-largest convenience store chain with its 2,900 locations primarily positioned in the Midwest United States. About half of Casey's stores are located in rural towns with populations under 5,000. While fueling stations serve as a key traffic driver, about two thirds of the company's gross profit stems from in-store sales of grocery items, prepared meals, and general merchandise. Casey's owns more than 90% of its stores and operates most of its warehousing and distribution processes internally.

Share on Social Networks: